Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


FORM 8-K

 


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 3, 2007

 


THE COOPER COMPANIES, INC.

(Exact name of registrant as specified in its charter)

 


 

Delaware   1-8597   94-2657368

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

6140 Stoneridge Mall Road, Suite 590, Pleasanton, California 94588

(Address of principal executive offices)

(925) 460-3600

(Registrant’s telephone number, including area code)

 


Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 3, 2007, The Cooper Companies, Inc. issued a press release to announce management changes with Robert S. Weiss, currently Cooper’s executive vice president and chief operating officer, assuming additional duties as president of CooperVision, Inc., reporting to A. Thomas Bender, Cooper’s chairman and chief executive officer. Mr. Weiss will have direct responsibility for CooperVision’s worldwide business and for CooperSurgical, the Company’s women’s health medical device business. Steven M. Neil, currently vice president and chief financial officer, has been named executive vice president and chief financial officer, reporting to Mr. Weiss. His expanded role will include overseeing the integration of CooperVision’s financial and information technology functions into the Company’s headquarters’ operations. Gregory A. Fryling, currently president of CooperVision, Inc., will be leaving CooperVision to pursue other opportunities.

The release also said that Mr. Bender has expressed his desire to relinquish his role as chief executive officer by the end of 2007, but expects to have a continuing role in the Company thereafter. Cooper’s Board has been engaged in a succession planning process and is considering both internal and external candidates for chief executive officer in its search process.

A copy of this release is attached as Exhibit 99.1 and incorporated herein by reference.

Internet addresses in the release are for information purposes only and are not intended to be hyperlinks to other Cooper Companies information.

 

ITEM 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.  

Description

99.1   Press Release dated April 3, 2007, of The Cooper Companies, Inc.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

THE COOPER COMPANIES, INC.
By  

/s/ Rodney E. Folden

  Rodney E. Folden
 

Corporate Controller

(Principal Accounting Officer)

Dated: April 3, 2007


EXHIBIT INDEX

 

Exhibit No.  

Description

99.1   Press Release dated April 3, 2007, of The Cooper Companies, Inc.
Press Release

Exhibit 99.1

 

LOGO

    LOGO
NEWS RELEASE     21062 Bake Parkway
    Lake Forest, CA 92630

CONTACT:

    888-822-2660
    Fax: 949-597-0662

Norris Battin

   

The Cooper Companies, Inc.

   

ir@coopercompanies.com

   

FOR IMMEDIATE RELEASE

   

THE COOPER COMPANIES ANNOUNCES RESTRUCTURING AND MANAGEMENT CHANGES

LAKE FOREST, Calif., April 3, 2007 — The Cooper Companies, Inc. (NYSE:COO) said today that as part of the continuing integration of Ocular Sciences, Inc., which was acquired in January of 2005, it is combining its CooperVision and Cooper Companies headquarters operations and announced the following management changes.

 

   

Robert S. Weiss, currently Cooper’s executive vice president and chief operating officer has assumed additional duties as president of CooperVision, Inc., reporting to A. Thomas Bender, Cooper’s chairman and chief executive officer. Weiss will have direct responsibility for CooperVision’s worldwide business and for CooperSurgical, the Company’s women’s health medical device business.

 

   

Steven M. Neil, currently vice president and chief financial officer, has been named executive vice president and chief financial officer, reporting to Weiss. His expanded role will include overseeing the integration of CooperVision’s financial and information technology functions into the Company’s headquarters’ operations.

 

   

Gregory A. Fryling, currently president of CooperVision, Inc., will be leaving CooperVision to pursue other opportunities.

Commenting on the new structure, Bender said, “We are nearing the completion of our three-year integration plan following the acquisition of Ocular. Combining CooperVision and The Cooper Companies headquarters is an important step in streamlining our business.

“I want to personally thank Greg Fryling for 22 years of service and an outstanding job throughout the Ocular integration process. Over the years, Greg played a key role in CooperVision’s business development program leading our efforts to acquire Aspect Vision, Biocompatibles and Ocular Sciences. We wish him every success in the future.”


Separately, the Company said that Bender has expressed his desire to relinquish his role as chief executive officer by the end of 2007, but expects to have a continuing role in the Company thereafter. Cooper’s Board has been engaged in a succession planning process and is considering both internal and external candidates for chief executive officer in its search process.

Corporate Information

The Cooper Companies, Inc. manufactures and markets specialty healthcare products through its CooperVision and CooperSurgical units. Corporate offices are in Lake Forest and Pleasanton, Calif. The World Wide Web address is www.coopercos.com. A toll free interactive telephone system at 1-800-334-1986 provides stock quotes, recent press releases and financial data.

CooperVision manufactures and markets contact lenses. Headquartered in Pleasanton, Calif., it manufactures in Juana Diaz, Puerto Rico, Norfolk, Va., Rochester, N.Y., Adelaide, Australia, Hamble and Hampshire England, Ligny-en-Barrios, France, and Madrid, Spain. Its Web address is www.coopervision.com.

CooperSurgical manufactures and markets diagnostic products, surgical instruments and accessories to the women’s healthcare market. With headquarters and manufacturing facilities in Trumbull and Orange, Conn., and in Pasadena, Calif., Houston, Texas, North Normandy, Ill., Williston, Vt., Fort Atkinson, Wis., Montreal and Berlin. Its Web address is www.coopersurgical.com

The information on Cooper’s Web sites and its interactive telephone system are not part of this announcement.

# # #